APA (7th ed.) Citation

Alcántara Montero, A. (2025). Reassessing Gabapentinoids in Chronic Obstructive Pulmonary Disease: Emerging Respiratory Safety Concerns. Chronic obstructive pulmonary disease, 22(1), 2542157. https://doi.org/10.1080/15412555.2025.2542157

Chicago Style (17th ed.) Citation

Alcántara Montero, A. "Reassessing Gabapentinoids in Chronic Obstructive Pulmonary Disease: Emerging Respiratory Safety Concerns." Chronic Obstructive Pulmonary Disease 22, no. 1 (2025): 2542157. https://doi.org/10.1080/15412555.2025.2542157.

MLA (9th ed.) Citation

Alcántara Montero, A. "Reassessing Gabapentinoids in Chronic Obstructive Pulmonary Disease: Emerging Respiratory Safety Concerns." Chronic Obstructive Pulmonary Disease, vol. 22, no. 1, 2025, p. 2542157, https://doi.org/10.1080/15412555.2025.2542157.